表紙
市場調査レポート

製薬業の提携・ライセンス・投資・M&A取引と動向

Partnerships, Licensing, Investments and M&A Deals and Trends for 2015 in Pharmaceuticals

発行 GlobalData 商品コード 331738
出版日 ページ情報 英文 173 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
製薬業の提携・ライセンス・投資・M&A取引と動向 Partnerships, Licensing, Investments and M&A Deals and Trends for 2015 in Pharmaceuticals
出版日: 2016年04月04日 ページ情報: 英文 173 Pages
概要

当レポートでは、世界の製薬業の提携・ライセンス・M&A・資金調達に関する主要データと動向分析に焦点を当てて、過去5年間の取引件数と取引額 (取引タイプ・治療分野・地域別) について検証し、製薬業の投資顧問会社に関する情報も含めて、体系的な情報を提供しています。

第1章 目次

第2章 世界の製薬・医療市場:取引サマリー

  • 取引分析
  • タイプ別、取引件数
  • タイプ別、取引額
  • 主要取引
  • 主要取引サマリー

第3章 世界の製薬・医療市場:主要取引契約者

第4章 世界の製薬・医療市場:取引サマリー (タイプ別)

  • M&A
  • 株式発行取引
  • 債券発行取引
  • 提携取引
  • ライセンス契約
  • 未公開株式発行取引
  • ベンチャーキャピタル取引

第5章 世界の製薬・医療市場:取引サマリー (市場別)

  • 腫瘍
  • 中枢神経系
  • 感染症
  • 免疫系
  • 心血管系
  • 代謝障害
  • 消化管

第6章 製薬・医療市場:取引サマリー (地域別)

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第7章 世界の製薬・医療市場:主要投資顧問会社

  • M&A
  • 株式発行

第8章 その他の情報

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDPH0492AD

GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for 2015 in Pharmaceuticals" report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in 2015. The report portrays detailed comparative data on the number of deals and their value in the last five years, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData's proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

  • Analysis of the market trends for the pharmaceutical industry in the global arena.
  • Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
  • Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
  • Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
  • Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
  • Analysis of partnership and licensing deals based on clinical stage of development of products.
  • Summary of the pharmaceutical deals globally in the last five years.
  • Information on the top deals happened in the pharmaceutical industry.
  • Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
  • League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

  • Enhance your decision making capability in a more rapid and time sensitive manner.
  • Find out the major deal performing segments for investments in your industry.
  • Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
  • Identify companies that are aggressively looking to raise capital in the market
  • Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
  • Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
  • Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
  • Identify growth segments and opportunities in each region within the industry.
  • Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Pharmaceutical & Healthcare, Global, Deals Summary

  • 2.1. Pharmaceutical & Healthcare, Global, Deals Analysis, 2015
    • 2.1.1. Pharmaceuticals & Healthcare, Global, Deals Analysis, 2015 by Quarter
  • 2.2. Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, 2015
  • 2.3. Pharmaceuticals & Healthcare, Global, by Type, Deal Values, 2015
  • 2.4. Pharmaceuticals & Healthcare, Global, Top Deals, 2015
  • 2.5. Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2015
    • 2.5.1. Allergan and Pfizer to Combine in USD160 Billion Deal
    • 2.5.2. Teva Pharma to Acquire Generics Drug Business from Allergan for USD40.5 Billion
    • 2.5.3. Actavis Raises USD21 Billion in Public Offering of Senior Notes
    • 2.5.4. AbbVie Acquires Pharmacyclics
    • 2.5.5. Pfizer Acquires Hospira for USD17 Billion
    • 2.5.6. Danaher Acquires Pall for USD13.8 Billion
    • 2.5.7. CVS Health Acquires Omnicare for USD12.9 Billion
    • 2.5.8. UnitedHealth Acquires Catamaran for USD12.8 Billion
    • 2.5.9. Valeant Pharma Acquires Salix Pharma for USD10.9 Billion
    • 2.5.10. AbbVie Raises USD16.7 Billion in Public Offering of Notes

3. Pharmaceuticals & Healthcare, Global, Top Deal Makers, 2015

4. Pharmaceuticals & Healthcare, Global, Deal Summary, by Type

  • 4.1. Pharmaceuticals & Healthcare, Global, M&A, 2015
    • 4.1.1. Pharmaceuticals & Healthcare, Global, M&A, 2015 by Quarter
    • 4.1.2. Top M&A Deals in 2015
    • 4.1.3. Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, 2015
  • 4.2. Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2015
    • 4.2.1. Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2015 by Quarter
    • 4.2.2. Pharmaceuticals & Healthcare, Global, IPO Deals, 2015
    • 4.2.3. Top IPOs in 2015
    • 4.2.4. Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, 2015
    • 4.2.5. Top Secondary Offerings in 2015
    • 4.2.6. Pharmaceuticals & Healthcare, Global, PIPE Deals, 2015
    • 4.2.7. Top PIPE Deals in 2015
    • 4.2.8. Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, 2015
  • 4.3. Pharmaceuticals & Healthcare, Global, Debt Offering Deals, 2015
    • 4.3.1. Pharmaceuticals & Healthcare, Global Debt Offerings, 2015 by Quarter
    • 4.3.2. Pharmaceuticals & Healthcare, Global, Public Debt Offerings, 2015
    • 4.3.3. Top Public Debt Offerings in 2015
    • 4.3.4. Pharmaceuticals & Healthcare, Global, Private Debt Placements, 2015
    • 4.3.5. Top Private Debt Placements in 2015
    • 4.3.6. Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, 2015
  • 4.4. Pharmaceuticals & Healthcare, Global, Partnership Deals, 2015
    • 4.4.1. Pharmaceuticals & Healthcare, Global, Partnership Deals, 2015 by Quarter
    • 4.4.2. Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, 2015
    • 4.4.3. Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Value (US$ m), 2015
    • 4.4.4. Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2015
    • 4.4.5. Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, 2015
    • 4.4.6. Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), 2015
    • 4.4.7. Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2015
    • 4.4.8. Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, 2015
    • 4.4.9. Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2015
    • 4.4.10. Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2015
  • 4.5. Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2015
    • 4.5.1. Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2015 by Quarter
    • 4.5.2. Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, 2015
    • 4.5.3. Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Value (US$ m), 2015
    • 4.5.4. Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2015
    • 4.5.5. Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2015
    • 4.5.6. Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2015
    • 4.5.7. Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2015
    • 4.5.8. Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Values, 2015
    • 4.5.9. Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2015
    • 4.5.10. Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2015
  • 4.6. Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2015
    • 4.6.1. Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2015 by Quarter
    • 4.6.2. Top Private Equity Deals in 2015
    • 4.6.3. Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, 2015
  • 4.7. Pharmaceuticals & Healthcare, Global, Venture Capital Deals, 2015
    • 4.7.1. Pharmaceuticals & Healthcare, Global, Venture Financing Deals, 2015 by Quarter
    • 4.7.2. Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2015
    • 4.7.3. Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2015
    • 4.7.4. Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, 2015
    • 4.7.5. Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year
    • 4.7.6. Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, 2015
    • 4.7.7. Top Venture Financing Deals in 2015

5. Pharmaceuticals & Healthcare, Global, Deal Summary, By Market

  • 5.1. Pharmaceuticals & Healthcare, Global, Oncology Deals, 2015
    • 5.1.1. Pharmaceuticals & Healthcare, Global, Oncology Deals, 2015 by Quarter
    • 5.1.2. Oncology - Deals of the Year
  • 5.2. Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2015
    • 5.2.1. Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2015 by Quarter
    • 5.2.2. Central Nervous System - Deals of the Year
  • 5.3. Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2015
    • 5.3.1. Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2015 by Quarter
    • 5.3.2. Infectious Disease - Deals of the Year
  • 5.4. Pharmaceuticals & Healthcare, Global, Immunology Deals, 2015
    • 5.4.1. Pharmaceuticals & Healthcare, Global, Immunology Deals, 2015 by Quarter
    • 5.4.2. Immunology - Deals of the Year
  • 5.5. Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2015
    • 5.5.1. Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2015 by Quarter
    • 5.5.2. Cardiovascular - Deals of the Year
  • 5.6. Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2015
    • 5.6.1. Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2015 by Quarter
    • 5.6.2. Metabolic Disorders - Deals of the Year
  • 5.7. Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2015
    • 5.7.1. Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2015 by Quarter
    • 5.7.2. Gastrointestinal - Deals of the Year

6. Pharmaceuticals & Healthcare, Deal Summary, By Geography

  • 6.1. Pharmaceuticals & Healthcare, North America Region, Deals, 2015
    • 6.1.1. Pharmaceuticals & Healthcare, North America Region, Deals, 2015 by Quarter
    • 6.1.2. North America - Deals of the Year
  • 6.2. Pharmaceuticals & Healthcare, European Region Deals, 2015
    • 6.2.1. Pharmaceuticals & Healthcare, Europe, Deals, 2015 by Quarter
    • 6.2.2. Europe - Deals of the Year
  • 6.3. Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, 2015
    • 6.3.1. Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, 2015 by Quarter
    • 6.3.2. Asia-Pacific - Deals of the Year
  • 6.4. Pharmaceuticals & Healthcare, Rest of the World (ROW) Deals, 2015
    • 6.4.1. Pharmaceuticals & Healthcare, Rest of the World Deals, 2015 by Quarter
    • 6.4.2. Rest of the World - Deals of the Year

7. Pharmaceuticals & Healthcare, Global, Top Financial Advisors

  • 7.1. Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2015
  • 7.2. Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2015

8. Further Information

  • 8.1. Methodology
  • 8.2. About GlobalData
  • 8.3. Disclosure information
  • 8.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical & Healthcare, Global, Deals Summary, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Table 2: Pharmaceuticals & Healthcare, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), 2015
  • Table 4: Pharmaceuticals & Healthcare, Top Deals, Global, 2015
  • Table 5: Pharmaceuticals & Healthcare, Global, Top Deal Makers, Number of Deals and Deal Value (US$ m), 2015
  • Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 7: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 8: Pharmaceuticals & Healthcare, Global, Top M&A Deals, 2015
  • Table 9: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, 2015
  • Table 10: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 11: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 12: Pharmaceuticals & Healthcare, Global, IPO Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Table 13: Pharmaceuticals & Healthcare, Global, Top IPOs, 2015
  • Table 14: Pharmaceuticals & Healthcare, Global, Secondary Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Table 15: Pharmaceuticals & Healthcare, Global, Top Secondary Offerings, 2015
  • Table 16: Pharmaceuticals & Healthcare, Global, PIPEs, Deals Summary, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Table 17: Pharmaceuticals & Healthcare, Global, Top PIPE Deals, 2015
  • Table 18: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2015
  • Table 19: Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 20: Pharmaceuticals & Healthcare, Global, Debt Offering, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 21: Pharmaceuticals & Healthcare, Global, Public Debt Offerings, Deals Summary, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Table 22: Pharmaceuticals & Healthcare, Global, Top Public Debt Offerings, 2015
  • Table 23: Pharmaceuticals & Healthcare, Global, Private Debt Placements, Deals Summary, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Table 24: Pharmaceuticals & Healthcare, Global, Top Private Debt Placements, 2015
  • Table 25: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Summary, Number of Deals and Deal Values (US$ m), 2015
  • Table 26: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 27: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 28: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2015
  • Table 29: Pharmaceuticals & Healthcare, Partnership Deals, Upfront & Milestone Payment and Deal Values (US$ m), 2015
  • Table 30: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2015
  • Table 31: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2015
  • Table 32: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payment and Deal Values (US$ m), 2015
  • Table 33: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payment and Deal Values (US$ m), 2015
  • Table 34: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, 2015
  • Table 35: Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payment, 2015
  • Table 36: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 37: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 38: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2015
  • Table 39: Pharmaceuticals & Healthcare, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2015
  • Table 40: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payments and Deal Values (US$ m), 2015
  • Table 41: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Q4 2014 - Q4 2015
  • Table 42: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Values (US$ m), 2015
  • Table 43: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront & Milestone Payment and Deal Values (US$ m), 2015
  • Table 44: Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Upfront Payment, 2015
  • Table 45: Pharmaceutical & Healthcare, Global, Top Licensing Agreements, by Milestone Payment, 2015
  • Table 46: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 47: Pharmaceuticals & Healthcare, Global, Private Equity, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 48: Pharmaceuticals & Healthcare, Global, Top Private Equity Deals, 2015
  • Table 49: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2015
  • Table 50: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 51: Pharmaceuticals & Healthcare, Global, Venture Capital, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 52: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals and Deal Values (%), 2015
  • Table 53: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Deals Summary, Number of Deals and Deal Values (US$ m), 2015
  • Table 54: Pharmaceutical & Healthcare, Global, Top VC Backed Companies, 2015
  • Table 55: Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2015
  • Table 56: Pharmaceuticals & Healthcare, Top Venture Financing Deals, Global, 2015
  • Table 57: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 58: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 59: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 60: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 61: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 62: Pharmaceuticals & Healthcare, Global, Infectious Disease, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 63: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 64: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 65: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 66: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 67: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 68: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 69: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Table 70: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Table 71: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Table 72: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Table 73: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Table 74: Pharmaceuticals & Healthcare, European Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Table 75: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Table 76: Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, Deals Summary, Global, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Table 77: Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Table 78: Pharmaceuticals & Healthcare, Rest of the World Deals, Deals Summary, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Table 79: Pharmaceuticals & Healthcare, Global,, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2015
  • Table 80: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2015

List of Figures

  • Figure 1: Pharmaceutical & Healthcare, Global, Number of Deals and Deal Value (US$ m), 2011- 2015
  • Figure 2: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Figure 3: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), 2015
  • Figure 4: Pharmaceuticals & Healthcare, Global, Deal Values (%), 2015
  • Figure 5: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 6: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 7: Pharmaceuticals & Healthcare, Global, M&As, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2015
  • Figure 8: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 10: Pharmaceuticals & Healthcare, Global, IPO Deals, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Figure 11: Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Figure 12: Pharmaceuticals & Healthcare, Global, PIPE Deals, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Figure 13: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2015
  • Figure 14: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 15: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 16: Pharmaceuticals & Healthcare, Global, Public Debt Offering Deals, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Figure 17: Pharmaceuticals & Healthcare, Global, Private Debt Placements, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Figure 18: Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2015
  • Figure 19: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 20: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 21: Pharmaceuticals & Healthcare, Global, Partnership Deals Break down (%), 2015
  • Figure 22: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), 2015
  • Figure 23: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront & Milestone Payments and Deal Values (US$ m), 2015
  • Figure 24: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2015
  • Figure 25: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2015
  • Figure 26: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, 2015
  • Figure 27: Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2015
  • Figure 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 29: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 30: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Number of Deals and Deal Values (US$ m), 2015
  • Figure 31: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Upfront & Milestone Payments and Deal Values (US$ m), 2015
  • Figure 32: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, Upfront & Milestone Payment and Deal Values (US$ m), 2015
  • Figure 33: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Number Of Deals, 2015
  • Figure 34: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Deal Values (US$ m), 2015
  • Figure 35: Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payment and Deal Values (US$ m), 2015
  • Figure 36: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 37: Pharmaceuticals & Healthcare, Global, Private Equity, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 38: Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2015
  • Figure 39: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 40: Pharmaceuticals & Healthcare, Global, Venture Capital, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 41: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Number Of Deals (%), 2015
  • Figure 42: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Deal Values (%), 2015
  • Figure 43: Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, 2015
  • Figure 44: Pharmaceuticals & Healthcare, Top Venture Financing Firms, Global, Number of Deals and Deal Value (US$ m), 2015
  • Figure 45: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 46: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 47: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), 2015, 2011 - 2015
  • Figure 48: Pharmaceuticals & Healthcare, Central Nervous System, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 49: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Figure 50: Pharmaceuticals & Healthcare, Global, Infectious Disease, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Figure 51: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 52: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 53: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 54: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 55: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 56: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 57: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), 2011 - 2015
  • Figure 58: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q1 2015-Q4 2015
  • Figure 59: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Figure 60: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Figure 61: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Figure 62: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Figure 63: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Figure 64: Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Figure 65: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), 2011 - 2015
  • Figure 66: Pharmaceuticals & Healthcare, Rest of the World Deals, Number of Deals and Deal Value (US$ m), Q1 2015-Q4 2015
  • Figure 67: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Value (US$ m), 2015
  • Figure 68: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Value (US$ m), 2015
Back to Top